Induction of immunity using inhibitors of granzymes
AssigneeThe University of Chicago
InventorsPhilip G. Ashton-Rickardt, Joseph T. Opferman
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University of Chicago
InventorsPhilip G. Ashton-Rickardt, Joseph T. Opferman
Estimating the term…
The present invention provides methods for enhancing host immunity to a virus and/or a cancer and methods for enhancing the cytotoxic T-cell (CTL) mediated immune responses by providing granzyme B inhibitors to a subject. One objective of the invention is to induce long-term protective immunity to a subject in need thereof This is accomplished by providing granzyme inhibitors to the subject which increase the number of memory-CTLs and thereby prevent or alleviate viral infections and/or treat. Providing granzyme inhibitors is also effective in the prevention of cancers. Some examples of granzyme inhibitors contemplated within the present invention include the endogenous serpins such as SPI6 and PI9, other suicide substrates of granzyme B, granzyme B antibodies, etc. Also provided are methods for expression of nucleic acids encoding granzyme inhibitors in cytotoxic T-lymphocytes (CTLs).
A method for enhancing or inducing immunity comprising administering to a patient a composition comprising a granzyme inhibitor.
A method for enhancing or inducing immunity comprising expressing a granzyme inhibitor in the cytotoxic T-lymphocytes of a subject by introducing an expression construct comprising a DNA segment encoding the granzyme inhibitor under the control of a promoter active in the cytotoxic T-lymphocyte.
A method for enhancing or inducing immunity comprising:
A method for inducing or enhancing immunity comprising:
Dependencies are inferred from the claim text.